Linden Thomas Advisory Services’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.06M Buy
65,893
+7,218
+12% +$260K 0.25% 124
2026
Q1
$1.44M Buy
58,675
+30,570
+109% +$724K 0.14% 258
2025
Q4
$697K Sell
28,105
-560
-2% -$14.9K 0.07% 358
2025
Q3
$813K Buy
28,665
+1,199
+4% +$32.5K 0.08% 334
2025
Q2
$683K Buy
27,466
+10,403
+61% +$293K 0.08% 357
2025
Q1
$529K Buy
17,063
+1,816
+12% +$60.5K 0.07% 368
2024
Q4
$481K Buy
15,247
+2,883
+23% +$137K 0.06% 387
2024
Q3
$716K Buy
12,364
+1,872
+18% +$92K 0.1% 324
2024
Q2
$426K Buy
10,492
+952
+10% +$37.8K 0.07% 374
2024
Q1
$401K Buy
9,540
+330
+4% +$12.9K 0.06% 378
2023
Q4
$353K Buy
9,210
+1,942
+27% +$64.7K 0.07% 361
2023
Q3
$224K Buy
7,268
+933
+15% +$32.2K 0.05% 370
2023
Q2
$200K Buy
+6,335
New +$217K 0.04% 357

Other funds holding ASTH

Linden Thomas Advisory Services's ASTH Position: Q2 2026 in Review

Linden Thomas Advisory Services increased its Astrana Health (ASTH) stake by 12% in Q2 2026, buying an estimated $260K and bringing the position to 65,893 shares worth $3.06M. The position accounts for 0.25% of the portfolio, ranked #124.

Linden Thomas Advisory Services first reported a position in ASTH in Q2 2023 and has held it in 13 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Linden Thomas Advisory Services held 65,893 shares of Astrana Health worth $3.06M as of Q2 2026.
  • Linden Thomas Advisory Services bought 7,218 Astrana Health shares in Q2 2026, an estimated $260K.
  • Astrana Health made up 0.25% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #124 holding.
  • Linden Thomas Advisory Services first reported a position in Astrana Health in Q2 2023 and has held it in 13 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.